Fund Name

$ Value

% Port.

STOCK

COMMON STOCK

$ Bought

% Increased

% Reduced

$ Sold

Shares

Percent

Date

Type

% Portfolio

% Chg

$ Change

$ Held

# Shares

Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of various types of cancer, including renal cell carcinoma and melanoma. The company was formerly known as Aquinox Pharmaceuticals, Inc. and changed its name to Neoleukin Therapeutics, Inc. in August 2019. Neoleukin Therapeutics, Inc. was founded in 2003 and is headquartered in Seattle, Washington.

Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders u...

Datesorted ascending	Fund Name	Type	% Portfolio	% Chg	$ Change	$ Held	# Shares
2023-08-09	Endurance Wealth Management, Inc.	SOLD OFF	Premium	Premium	Premium	Premium	-
2022-11-03	ACT CAPITAL MANAGEMENT, LLC	UNCHANGED	Premium	Premium	Premium	Premium	199,000
2022-10-17	Highland Private Wealth Management	UNCHANGED	Premium	Premium	Premium	Premium	46,999
2022-05-16	Amalgamated Financial Corp.	NEW	Premium	Premium	Premium	Premium	4,621
2022-05-16	Parametric Portfolio Associates LLC	ADDED	Premium	Premium	Premium	Premium	116,780
2022-04-04	Dixon Hughes Goodman Wealth Advisors LLC	NEW	Premium	Premium	Premium	Premium	100
2021-08-16	PICTET ASSET MANAGEMENT LTD	ADDED	Premium	Premium	Premium	Premium	2,043,890

Fund Name	# Shares	$ Value	% Port.
PICTET ASSET MANAGEMENT LTD	2,043,890	18,865,000	0.02%
ACT CAPITAL MANAGEMENT, LLC	199,000	127,000	0.17%
Parametric Portfolio Associates LLC	116,780	220,000	-
Highland Private Wealth Management	46,999	30,000	-
Amalgamated Financial Corp.	4,621	9,000	-
Dixon Hughes Goodman Wealth Advisors LLC	100	-	-
Endurance Wealth Management, Inc.	-	-	-

Fund Name	$ Value	% Port.
ACT CAPITAL MANAGEMENT, LLC	127,000	0.17%
PICTET ASSET MANAGEMENT LTD	18,865,000	0.02%
Dixon Hughes Goodman Wealth Advisors LLC	-	-
Amalgamated Financial Corp.	9,000	-
Parametric Portfolio Associates LLC	220,000	-
Endurance Wealth Management, Inc.	-	-
Highland Private Wealth Management	30,000	-

Fund Name	$ Bought
Amalgamated Financial Corp.	9,000
Dixon Hughes Goodman Wealth Advisors LLC	-

Fund Name	% Increased
Parametric Portfolio Associates LLC	7.17
PICTET ASSET MANAGEMENT LTD	1.78

NLTX - Neoleukin Therapeutics Inc Stock Price, Fair Value and News

Which funds bought or sold NLTX recently?

Which funds are the top buyers of NLTX?

Which funds have put a big percent of portfolio in NLTX?

Trend of No. of funds that hold NLTX

Changes in Positions

Investor Breakout

Investor Churn (# Increased Holdings)

New Buys

Additions

Sold off